Dosage form

- Kenvue Brands LLC
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a first perspective view of a dosage form;

FIG. 2 is a top plan view of the dosage form of FIG. 1;

FIG. 3 is a bottom plan view of the dosage form of FIG. 1;

FIG. 4 is a top plan view of the dosage form of FIG. 1;

FIG. 5 is a side view, in elevation, of a first side of the dosage form of FIG. 1;

FIG. 6 is a side view, in elevation, of a second side of the dosage form of FIG. 1;

FIG. 7 is a side view, in elevation, of a third side of dosage form of FIG. 1; and,

FIG. 8 is a second perspective view of the dosage form of FIG. 1.

The broken lines are included for the purpose of illustrating portions of the dosage form and form no part of the claimed design.

Claims

The ornamental design for a dosage form, as shown and described.

Referenced Cited
U.S. Patent Documents
D255727 July 1, 1980 Grodin
D285490 September 2, 1986 Tovey
D285491 September 2, 1986 Tovey
4713248 December 15, 1987 Kjornaes
4735805 April 5, 1988 Ni
D301764 June 20, 1989 Contractor
D302051 July 4, 1989 Contractor
D359554 June 20, 1995 Dansereau et al.
D377085 December 31, 1996 Tortarolo
D377086 December 31, 1996 Tortarolo
D403396 December 29, 1998 Lundbom et al.
D408910 April 27, 1999 Lundbom et al.
D425614 May 23, 2000 Chen et al.
D430285 August 29, 2000 Chen et al.
D431076 September 19, 2000 Chen
D433122 October 31, 2000 Burrows
D433501 November 7, 2000 Burrows
D434135 November 21, 2000 Burrows
D434136 November 21, 2000 Burrows
D434846 December 5, 2000 Chen
D437407 February 6, 2001 Burrows
D506544 June 21, 2005 Rinker et al.
D515202 February 14, 2006 Chen et al.
D521187 May 16, 2006 Jackel-Marken
D534646 January 2, 2007 Chang et al.
D564086 March 11, 2008 Nielsen et al.
D636070 April 12, 2011 Illing et al.
D636865 April 26, 2011 Vepuri
D641863 July 19, 2011 Spengler
D671636 November 27, 2012 Nishino
D685460 July 2, 2013 Illing
D717423 November 11, 2014 Heit
D735315 July 28, 2015 Bhat
D736369 August 11, 2015 Bruining et al.
D741990 October 27, 2015 Ramos
D754840 April 26, 2016 Waldman et al.
D754841 April 26, 2016 Waldman et al.
D755949 May 10, 2016 Ramos
D768283 October 4, 2016 Evans, II
D771236 November 8, 2016 Becker
D773641 December 6, 2016 Sadler
D813372 March 20, 2018 Parikh et al.
D835257 December 4, 2018 Parikh et al.
D835258 December 4, 2018 Parikh et al.
D837967 January 8, 2019 Cannamela et al.
D858741 September 3, 2019 Parikh et al.
D906513 December 29, 2020 Asmussen
D907760 January 12, 2021 Hassan et al.
D918377 May 4, 2021 Cannamela et al.
D947358 March 29, 2022 Asmussen
D1017017 March 5, 2024 Daugherity
20080317678 December 25, 2008 Szymczak
20110244040 October 6, 2011 Ono
Other references
  • [Motrin Dual Action with Tylenol, Dual Action Pain Reliever with Ibuprofen & Acetaminophen, Two Medicines for Minor Aches & Pains, Ibuprofen (NSAID) 125 mg & Acetaminophen 250 mg, 80 ct], Amazon.com, Date First Available: Feb. 22, 2023[online], site visited: [Sep. 11, 2024], URL: <https://www.amazon.com/Motrin-Reliever-Ibuprofen-Acetaminophen-Medicines/dp/B0BWKR3S66>. (Year: 2023).
Patent History
Patent number: D1071139
Type: Grant
Filed: Mar 13, 2023
Date of Patent: Apr 15, 2025
Assignee: Kenvue Brands LLC (Summit, NJ)
Inventors: Colin Pinto (Ambler, PA), David B. Cochran (Glenside, PA)
Primary Examiner: Bao-Yen T Nguyen
Assistant Examiner: Amanda J Berlinski
Application Number: 29/872,415
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)